Pennsylvania HB2592: An Act amending the act of October 24, 2018 (P.L.719, No.112), known as the Patient Test Result Information Act, further providing for definitions; providing for prostate-specific antigen test results; and further providing for duties of Department of Health.

What the bill says

An act providing for notification of patient test results to be sent directly to a patient or the patient's designee; and providing for duties of the Department of Health," further providing for definitions; providing for prostate-specific antigen test results; and further providing for duties of Department of Health.

From the introduced text, June 2, 2026:

An act providing for notification of patient test results to be sent directly to a patient or the patient's designee; and providing for duties of the Department of Health," further providing for definitions; providing for prostate-specific antigen test results; and further providing for duties of Department of Health. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 2 of the act of October 24, 2018 (P.L.719, No.112), known as the Patient Test Result Information Act, is amended by adding definitions to read: Section 2. Definitions. The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise: "Department." The Department of Health of the Commonwealth. * * * "Prostate-specific antigen test." A blood test that measures the amount of prostate-specific antigen in an individual's blood, which may indicate that an individual is at an increased risk of prostate cancer. * * * Section 2. The act is amended by adding a section to read: Section 3.1. Prostate-specific antigen test results. (a) Notice.--When, in the judgment of the entity performing a prostate-specific antigen test, an abnormal level of prostate- specific antigen may exist, the entity performing the prostate- specific antigen test shall directly notify the patient or the patient's designee by …

Read the full official text

Sponsors

• Keith Harris (D, 195) · primary sponsor
• Russ Diamond (R, 102)
• Tarik Khan (D, 194)
• Benjamin Sanchez (D, 153)
• Donald Cook (R, 50)
• Carol Hill-Evans (D, 95)
• Liz Hanbidge (D, HD-061)
• Nancy Guenst (D, 152)
• Benjamin Waxman (D, 182)
• Sean Dougherty (D, 172)
• Robert FREEMAN (D, 136)
• Timothy Brennan (D, 29)

Latest actions

1. June 2, 2026: Referred to HEALTH, June 2, 2026

Common questions

What is HB2592?

HB2592 is a bill in the Pennsylvania Legislature (2025-2026 Regular Session): An Act amending the act of October 24, 2018 (P.L.719, No.112), known as the Patient Test Result Information Act, further providing for definitions; providing for prostate-specific antigen test results; and further providing for duties of Department of Health.

What does HB2592 do?

In its own words: An act providing for notification of patient test results to be sent directly to a patient or the patient's designee; and providing for duties of the Department of Health," further providing for definitions; providing for prostate-specific antigen test results; and further providing for duties of Department of Health.

What is the status of HB2592?

In committee as of June 2, 2026. Latest action: Referred to HEALTH, June 2, 2026 (June 2, 2026).

Who sponsored HB2592?

Keith Harris (D, 195), with 11 co-sponsors.

Where is the official record for HB2592?

On the Pennsylvania Legislature website: https://www.palegis.us/legislation/bills/2025/hb2592